Emnar Pharma Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 19.87 Cr
as on 23-10-2024
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 70.30 Cr
as on 23-10-2024
- Satisfied Charges ₹ 36.91 Cr
as on 23-10-2024
- Revenue 13.11%
(FY 2023)
- Profit -6.78%
(FY 2023)
- Ebitda -4.10%
(FY 2023)
- Net Worth 8.50%
(FY 2023)
- Total Assets 3.65%
(FY 2023)
About Emnar Pharma
The Corporate was formerly known as Emmennar Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 19.87 Cr.
The company currently has active open charges totaling ₹70.30 Cr. The company has closed loans amounting to ₹36.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Emnar Pharma Private Limited India is Monika Sharma as COMPANY SECRETARY. Sudha Mundla, Vamshidhar Kallem, Mundla Vishnu, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299TG2002PTC039653
- Company No.
039653
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Emnar Pharma Private Limited offer?
Emnar Pharma Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Hormones and Steroid API, Paints, Wall Putty & Varnishes, Paint Thinners, Soaps, Detergent Powder & Cakes, Sodium Silicate, Blood System and Cardiovascular API, Anti Inflammatory and Immunosuppressant API, Fire Fighting & Prevention Products, Fire Extinguishing Agents.
Who are the key members and board of directors at Emnar Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monika Sharma  | Company Secretary | 24-Jul-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mundla Vishnu | Director | 01-Aug-2011 | Current |
| Sudha Mundla | Director | 23-Sep-2002 | Current |
| Vamshidhar Kallem | Director | 18-Nov-2013 | Current |
| Venkatarami Reddy | Director | 01-Aug-2015 | Current |
Financial Performance and Corporate Structure Insights of Emnar Pharma.
Emnar Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.11% increase. The company also saw a slight decrease in profitability, with a 6.78% decrease in profit. The company's net worth moved up by a moderate rise of 8.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emnar Pharma?
In 2023, Emnar Pharma had a promoter holding of 100.00%. The company had 3 Joint Ventures. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Virchow Petrochemical Private LimitedActive 21 years 6 monthsSudha Mundla, Vamshidhar Kallem and 1 more are mutual person
- Virchow Laboratories LimitedActive 42 years 11 months
Sudha Mundla and Mundla Vishnu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 04 May 2015 | ₹60.00 Cr | Open |
State Bank Of India Creation Date: 30 Aug 2010 | ₹10.30 Cr | Open |
Citi Bank N.A. Creation Date: 04 May 2015 | ₹30.00 Cr | Satisfied |
How Many Employees Work at Emnar Pharma?
Emnar Pharma has a workforce of 671 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emnar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emnar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
